Leukeran chlorambucil pricing – Aspen being investigated by EC for alleged overpricing

Aspen Pharma is being formally investigated by the European Commission on charges of excessively pricing its five life-saving cancer medicines including Leukeran chlorambucil. The European Commission’s investigation comes a... Read more »